A Report of Guillain–Barré Syndrome With Myalgia and Mild Weakness
نویسندگان
1 Pediatrics growth disorders research center, 17 Shahrivar Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
2 Pediatrics growth disorders research center, 17 Shahrivar Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
doi
10.22037/ijcn.v8i2.4853چکیده
How to Cite This Article: Aminzadeh V, Hassanzadeh Rad A. A Report of Guillain–Barré Syndrome With Myalgiaand Mild Weakness. Iran J Child Neurol. 2014 Spring; 8(2):70-72. We report a rare case that revealed severe myalgia as the chief complaint that is not mentioned in the list of frequent symptoms of Guillain Barré.Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating polyneuropathy (AIDP).Required features for diagnosis of GBS are progressive motor weakness of more than one limb and areflexia. We report an 11-yearoldboy who was referred to the emergency department with complaints of generalized body pain and gate problem.It seems that if myalgias are the chief complaint and weakness is mentioned as a less important symptom, clinicians should consider GBS after ruling out otherreasons for myalgia especially inflammatory myositis. References1. Landaverde JM, Danovaro-Holliday MC, Trumbo SP, Pacis-Tirso CL, Ruiz-Matus C. Guillain-Barré syndrome in children aged <15 years in Latin America and the Caribbean: baseline rates in the context of the influenza A (H1N1) pandemic. J Infect Dis 2010 Mar;201(5):746-50.2. Edward J. Filipponea, D Mitul Kanzariaa Rodney Bellb Eric Newmana, D John L. Farber. Secondary Membranous Nephropathy Associated with Guillain-Barré Syndrome. Case Rep Nephrol Urol 2013;3:34–39.3. Kuwabara S. Guillain-Barré syndrome: epidemiology, pathophysiology and management. Drugs 2004;64(6):597-610.4. Hughes RAC, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain 2007;130:2245-2257.5. Dy M, Leshner RL, Crawford JR An Unusual Case of Recurrent Guillain-Barre Syndrome of a Different Subtype Five Years after Initial Diagnosis.Case Rep N eurol Med 2013; 2013: 356157.6. McLean S, Sheng F, Oon SF. Childhood Guillain-Barre Syndrome: Comparing Intravenousimmunoglobulin Treatment with Supportive Care.Trinity Student Medical Journal. 2005; 6:60–7.7. Swaimann K. Ashwal S. Ferriero D. Pediatric neurology: principles and practice. 4th ed. Philadelphia: Mosby-Elsevier 2006.p 1920.8. Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2011;29:599-612.9. Hicks CW, Kay B, Worley SE, Moodley M. A clinical picture of Guillain-Barré syndrome in children in the United States. J Child Neurol 2010 Dec;25(12):1504-10.10. Borade A, Lad S, Ansari N, Dhongade R. Guillain-Barré syndrome in child with prolongintubation. Indian J Med Sci 2010 Jul;64(7):325-8.11. Roodbol J, de Wit MC, Walgaard C, de Hoog M, Catsman-Berrevoets CE, Jacobs BC. Recognizing Guillain-Barré syndrome in preschool children. Neurology 2011 Mar 1; 76(9):807-10.